BOCA RATON, FL--(Marketwire - April 21, 2008) - Vicor Technologies, Inc. (OTCBB: VCRT), a development-stage company commercializing the PD2i Cardiac Analyzer, a patented device utilized in risk stratification of patients for Sudden Cardiac Death (SCD), announces the conversion of $1,251,200 of its corporate debt into shares of common stock and warrants to purchase shares of its common stock.
